E N Parovichnikova Selected Research

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)

7/2021	[Extracorporeal cytokine removal in chimeric antigen receptor T-cell therapy associated cytokine release syndrome in patient with acute lymphoblastic leukemia. Case report].
9/2020	[Detection of activating mutations in RAS/RAF/MEK/ERK and JAK/STAT signaling pathways].
8/2018	Structure and significance of cytogenetic abnormalities in adult patients with Ph-negative acute lymphoblastic leukemia.
1/2016	[Acute Ph-negative lymphoblastic leukemias in adults: Risk factors in the use of the ALL-2009 protocol].
1/2013	[Cryptococcosis in hematology practice].
1/2013	[Efficiency of treatment of adult patients with acute T-lymphoblastic leukemia according to the ALL-2009 protocol of the Russian Acute Leukemia Study Group].
1/2011	[First results of Ph-negative acute lymphoblastic leukemia therapy of adults according to the protocol of Research Group of Russian Hematological Centers ALL-2009].
1/2011	[An extremely high serum methotrexate concentration associated with acute renal failure in a patient with acute lymphoblastic leukemia after conduction of high dose consolidation].
1/2007	[Transplantations of allogenic and autologous hemopoietic stem cells in acute leukemia (results of 20-year experience)].
1/2006	[Characteristics of T-cell immunity in patients with acute leukemia].

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

E N Parovichnikova Research Topics

Disease

14	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 07/2021 - 01/2001
13	Neoplasms (Cancer) 07/2021 - 01/2002
12	Leukemia 12/2023 - 01/2000
11	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 07/2021 - 01/2003
7	Residual Neoplasm 07/2021 - 01/2002
5	Acute Promyelocytic Leukemia 01/2013 - 01/2001
4	Infections 01/2017 - 01/2010
4	Hematologic Neoplasms (Hematological Malignancy) 01/2015 - 01/2007
3	Graft vs Host Disease (Graft-Versus-Host Disease) 05/2022 - 12/2014
3	Leukocytosis (Pleocytosis) 01/2017 - 01/2015
3	Disease Progression 01/2016 - 01/2013
3	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2016 - 01/2013
3	Agranulocytosis (Granulocytopenia) 01/2015 - 01/2013
3	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2014 - 01/2010
2	Multiple Myeloma 07/2021 - 01/2012
2	Aplastic Anemia (Anemia, Hypoplastic) 09/2020 - 08/2016
2	Chromosome Aberrations (Chromosome Abnormalities) 08/2018 - 01/2016
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2017 - 01/2016
2	Septic Shock (Toxic Shock Syndrome) 01/2015 - 01/2013
2	Pathologic Complete Response 01/2015 - 01/2013
2	Respiratory Insufficiency (Respiratory Failure) 01/2015 - 01/2009
2	Hematologic Diseases (Blood Diseases) 01/2014 - 01/2013
2	Lymphoma (Lymphomas) 01/2014 - 01/2013
2	Body Weight (Weight, Body) 06/2012 - 01/2012
1	COVID-19 10/2023
1	Primary Myelofibrosis (Myelosclerosis) 07/2021
1	Myeloid Sarcoma (Chloroma) 07/2021
1	Multiple Organ Failure (MODS) 07/2021
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 07/2021
1	Multiple Endocrine Neoplasia Type 2a (MEN 2) 07/2021
1	Shock 07/2021
1	Cytokine Release Syndrome 07/2021
1	Acute Myelomonocytic Leukemia 08/2019
1	Thyroiditis 08/2019
1	Gastroparesis 02/2018
1	Splenomegaly 01/2017
1	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (Leukemia, Pre B Cell) 01/2017
1	Cytomegalovirus Infections (Inclusion Disease) 11/2016
1	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 08/2016
1	Leukostasis 01/2015
1	Lung Injury 01/2015
1	T-Cell Leukemia (Leukemia, T Cell) 01/2015
1	Myeloid Leukemia (Leukemia, Myelocytic) 01/2015
1	Meningitis 01/2013
1	Cryptococcosis 01/2013
1	Meningoencephalitis 01/2013

Drug/Important Bio-Agent (IBA)

6	Cytostatic AgentsIBA 01/2015 - 01/2009
4	AntigensIBA 01/2013 - 01/2003
3	methionylmethylsulfonium chloride (MMSC)IBA 12/2014 - 01/2012
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2013 - 01/2003
3	Asparaginase (Elspar)FDA Link 01/2013 - 01/2003
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 06/2012 - 01/2000
3	Interferon-alpha (Interferon Alfa)IBA 01/2007 - 01/2001
2	CytokinesIBA 07/2021 - 01/2006
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2017 - 01/2016
2	Amphotericin B (Amphotericin)FDA LinkGeneric 01/2015 - 01/2013
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2013 - 01/2003
2	GlucocorticoidsIBA 01/2013 - 01/2013
2	Prednisolone (Predate)FDA LinkGeneric 01/2013 - 01/2009
2	Interleukin-2 (IL2)IBA 01/2007 - 01/2007
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2002 - 01/2001
1	AntioxidantsIBA 12/2023
1	Mitochondrial DNA (mtDNA)IBA 12/2023
1	Monoclonal AntibodiesIBA 10/2023
1	Proteins (Proteins, Gene)FDA Link 05/2022
1	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 08/2021
1	Indicators and Reagents (Reagents)IBA 07/2021
1	Chimeric Antigen ReceptorsIBA 07/2021
1	AndrogensIBA 07/2021
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 09/2020
1	Sorafenib (BAY 43-9006)FDA Link 08/2019
1	Botulinum Toxins (Botulinum Toxin)IBA 02/2018
1	Immunoglobulin M (IgM)IBA 01/2017
1	VDJ RecombinasesIBA 10/2016
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2016
1	Immunoglobulins (Immunoglobulin)IBA 01/2016
1	LigandsIBA 01/2015
1	KIR ReceptorsIBA 01/2015
1	Hydroxyurea (Hydrea)FDA LinkGeneric 01/2015
1	Rituximab (Mabthera)FDA Link 01/2014
1	VemurafenibIBA 01/2013
1	Antifungal AgentsIBA 01/2013

Therapy/Procedure

29	Therapeutics 12/2023 - 01/2001
9	Transplantation 07/2021 - 01/2002
8	Drug Therapy (Chemotherapy) 07/2021 - 01/2001
7	Hematopoietic Stem Cell Transplantation 05/2022 - 01/2014
5	Bone Marrow Transplantation (Transplantation, Bone Marrow) 09/2020 - 01/2002
4	Combination Drug Therapy (Combination Chemotherapy) 01/2015 - 01/2009
3	Remission Induction 07/2019 - 01/2013
2	Stem Cell Transplantation 07/2019 - 01/2014
2	Critical Care (Surgical Intensive Care) 07/2019 - 01/2009
2	Cell- and Tissue-Based Therapy (Cell Therapy) 10/2017 - 11/2016
2	Kidney Transplantation 01/2017 - 01/2013
2	Induction Chemotherapy 01/2015 - 01/2011
1	Hemodiafiltration 07/2021
1	Plasmapheresis 01/2015
1	Noninvasive Ventilation 01/2015
1	Injections 12/2014
1	Central Venous Catheters 01/2013
1	AIDA protocol 01/2013